⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL330308 | 1.00 | — | — | |
| SCHEMBL330011 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL28164671 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL29078950 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL11433892 | 0.97 | ALDH1A1 (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL28164672 | 0.97 | ALDH1A1 (0.48) | — | |
| Hydrochloric Acid SCHEMBL28235390 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL29078952 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL8968093 | 0.92 | ALDH1A1 (0.45) | — | |
| SCHEMBL3373326 | 0.90 | MME (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2164 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-4720103-A2 | THERAPEUTIC USES OF ADIPOSE-SECRETED SIGNALING PROTEIN (ADISSP) | University Of Massachusetts (US) | 2026-04-08 | — | — | EP | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260009800-A1 | METHODS OF DIAGNOSIS AND GUIDING TREATMENT OF VULVOVAGINAL SYMPTOMS AND FEMALE SEXUAL DYSFUNCTION | UNIV ARIZONA (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025245294-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245292-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245279-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-20250320265-A1 | BROWN FAT-SELECTIVE ADIPOKINES | UNIV MASSACHUSETTS (US) | 2025-10-16 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| EP-0864578-A2 | Platinum (IV) complex and pharmaceutical composition comprising the same | SS PHARMACEUTICAL CO., LTD. (JP) | 1998-09-16 | — | — | EP | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| EP-0451760-B1 | Nitrato alkanoic acid derivatives and method for their production | SANOL ARZNEI SCHWARZ GMBH (DE) | 1995-09-13 | — | — | EP | claimed |
| EP-0416282-B1 | Microbiologically produced N-Acyl-L-proline-acylase, process for its production and its use | DEGUSSA (DE) | 1994-09-14 | — | — | EP | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| EP-0558961-A2 | Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them | BEHRINGWERKE Aktiengesellschaft (DE) | 1993-09-08 | — | — | EP | claimed |
| US-5219741-A | Reacting in the presence of microbiologically produced N-acyl-L-proline acylase | DEGUSSA AG (DE) | 1993-06-15 | — | — | US | claimed |
| US-5120652-A | Synthesis of proline from acyl derivatives; thermostable | DEGUSSA AG (DE) | 1992-06-09 | — | — | US | claimed |
| EP-0056594-B1 | THYMOSIN-ALPHA-1 FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS WITH IMMUNOREGULATING ACTION CONTAINING THEM | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-09-12 | — | — | EP | claimed |
| US-4405638-A | ANTITUSSIVE AGENTS; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A (IT) | 1983-09-20 | — | — | US | claimed |